drugset / Trial / NCT01961271

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

NCT01961271

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of the buprenorphine transdermal patch (Norspan® or Sovenor® transdermal patch) in patients with chronic non-malignant pain of moderate to severe intensity due to osteoarthritis, rheumatoid arthritis, lower back pain and joint/muscle pain, who are not adequately responding to non-opioid painkillers.

Timeline

Start
2013-06
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 5 mg Other
Subject Buprenorphine Other / unclassified 10 mg Other
Subject Buprenorphine Other / unclassified 15 mg Other
Subject Buprenorphine Other / unclassified 20 mg Other
Subject Buprenorphine Other / unclassified 25 mg Other
Subject Buprenorphine Other / unclassified 30 mg Other
Subject Buprenorphine Other / unclassified 40 mg Other